- Home
- XNCR vs IBTA Comparison
XNCR vs IBTA Comparison
Compare XNCR & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | IBTA |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 855.3M |
| IPO Year | 2013 | 2024 |
Fundamental Metrics
Financial Performance| Metric | XNCR | IBTA |
|---|---|---|
| Price | $11.92 | $34.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | $22.33 | ★ $28.50 |
| AVG Volume (30 Days) | ★ 648.0K | 160.3K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $125,576,000.00 | ★ $342,389,000.00 |
| Revenue This Year | N/A | $2.02 |
| Revenue Next Year | $4.80 | $8.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $19.10 |
| 52 Week High | $18.69 | $50.50 |
Technical Indicators
Market Signals| Indicator | XNCR | IBTA |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 54.33 |
| Support Level | $10.83 | $21.23 |
| Resistance Level | $12.87 | $35.11 |
| Average True Range (ATR) | 0.58 | 2.23 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 49.60 | 77.41 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About IBTA Ibotta Inc.
Ibotta Inc operates a digital promotions platform, the Ibotta Performance Network (IPN), which connects consumer packaged goods (CPG) brands with consumers through a network of publishers. It sources digital offers from clients and distributes them via its technology platform, earning revenue when promotions result in consumer transactions. The platform supports offers across grocery and general merchandise categories, including toys, clothing, beauty, electronics, pet, and home products. The majority of its revenues is derived from the fees charged to clients when consumers redeem offers on the IPN by purchasing promoted products.